BioCentury | Jun 10, 2020
Emerging Company Profile

Autobahn: fine-tuning thyroid agonism to remyelinate axons

...member of Autobahn’s executive team is CSO Brian Sterns. He was VP of chemistry at Inception Sciences Inc....
BioCentury | Jan 11, 2020
Company News

Chinook to spin AbbVie castoff into personalized kidney disease candidate

...Inc. (NYSE:ABBV) also took an equity stake in the company. Chinook launched from Versant Ventures’ Inception Sciences...
BioCentury | Aug 22, 2019
Financial News

Eyeing new endpoints, Versant-backed Chinook reels in $65M series A for kidney therapies

...back newly launched Chinook with $65 million in series A funding. Incubated within Versant Ventures' Inception Sciences...
BioCentury | Nov 15, 2018
Product R&D

Tempest takes PPAR alpha into cancer

...cells to promote their antitumor activity (see “Raising Metabolism” ). Tempest emerged from Versant Ventures’ Inception Sciences Inc....
BioCentury | Nov 14, 2018
Preclinical News

Tempest data provide POC for PPAR alpha’s role in cancer

...but not either agent alone, were alive past day 24. Tempest launched from Versant Ventures' Inception Sciences Inc....
BioCentury | Nov 2, 2018
Finance

Bye-bye, build-to-buy

...As another Inception Sciences Inc. company secures an exit, Versant Ventures plans to move away from its build-to-buy...
...away from this model (see “Versant Bites at the Apple” ). Virginia Li, Assistant Editor Inception 4 Inc. Inception Sciences Inc. Ophthotech...
BioCentury | Apr 6, 2018
Company News

Roche aquires remyelination play Inception 5

...in and beyond remyelination. Inception 5 was spun out of Versant’s small molecule discovery engine Inception Sciences Inc....
...SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Inception 5 Inc., San Diego, Calif. Business: Autoimmune Selina Koch BlueRock Therapeutics Inception 5 Inc. Inception Sciences Inc. Roche Versant...
BioCentury | Apr 4, 2018
Company News

Roche acquires Versant's MS play Inception 5, VC launches another

...in and beyond remyelination. Inception 5 was spun out of Versant’s small molecule discovery engine Inception Sciences Inc....
BioCentury | Mar 30, 2018
Financial News

Versant launches Tempest with $70M

...Immuno-oncology company Tempest Therapeutics Inc. (San Francisco, Calif.) emerged from Versant Ventures' Inception Sciences Inc. incubator on March...
BioCentury | Mar 28, 2018
Financial News

Versant launches Tempest with $70M

...Immuno-oncology company Tempest Therapeutics Inc. (San Francisco, Calif.) emerged from Versant Ventures' Inception Sciences Inc. incubator with a...
Items per page:
1 - 10 of 37
BioCentury | Jun 10, 2020
Emerging Company Profile

Autobahn: fine-tuning thyroid agonism to remyelinate axons

...member of Autobahn’s executive team is CSO Brian Sterns. He was VP of chemistry at Inception Sciences Inc....
BioCentury | Jan 11, 2020
Company News

Chinook to spin AbbVie castoff into personalized kidney disease candidate

...Inc. (NYSE:ABBV) also took an equity stake in the company. Chinook launched from Versant Ventures’ Inception Sciences...
BioCentury | Aug 22, 2019
Financial News

Eyeing new endpoints, Versant-backed Chinook reels in $65M series A for kidney therapies

...back newly launched Chinook with $65 million in series A funding. Incubated within Versant Ventures' Inception Sciences...
BioCentury | Nov 15, 2018
Product R&D

Tempest takes PPAR alpha into cancer

...cells to promote their antitumor activity (see “Raising Metabolism” ). Tempest emerged from Versant Ventures’ Inception Sciences Inc....
BioCentury | Nov 14, 2018
Preclinical News

Tempest data provide POC for PPAR alpha’s role in cancer

...but not either agent alone, were alive past day 24. Tempest launched from Versant Ventures' Inception Sciences Inc....
BioCentury | Nov 2, 2018
Finance

Bye-bye, build-to-buy

...As another Inception Sciences Inc. company secures an exit, Versant Ventures plans to move away from its build-to-buy...
...away from this model (see “Versant Bites at the Apple” ). Virginia Li, Assistant Editor Inception 4 Inc. Inception Sciences Inc. Ophthotech...
BioCentury | Apr 6, 2018
Company News

Roche aquires remyelination play Inception 5

...in and beyond remyelination. Inception 5 was spun out of Versant’s small molecule discovery engine Inception Sciences Inc....
...SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Inception 5 Inc., San Diego, Calif. Business: Autoimmune Selina Koch BlueRock Therapeutics Inception 5 Inc. Inception Sciences Inc. Roche Versant...
BioCentury | Apr 4, 2018
Company News

Roche acquires Versant's MS play Inception 5, VC launches another

...in and beyond remyelination. Inception 5 was spun out of Versant’s small molecule discovery engine Inception Sciences Inc....
BioCentury | Mar 30, 2018
Financial News

Versant launches Tempest with $70M

...Immuno-oncology company Tempest Therapeutics Inc. (San Francisco, Calif.) emerged from Versant Ventures' Inception Sciences Inc. incubator on March...
BioCentury | Mar 28, 2018
Financial News

Versant launches Tempest with $70M

...Immuno-oncology company Tempest Therapeutics Inc. (San Francisco, Calif.) emerged from Versant Ventures' Inception Sciences Inc. incubator with a...
Items per page:
1 - 10 of 37